Abstract
This study further expands our previous observation demonstrating the usefulness of combination therapy of anti-TNF-alpha and Cyclosporine A in the treatment of rheumatoid arthritis and concurrent hepatitis C virus infection, as well its efficacy and safety in controlling HCV viremia and liver toxicity. Seven patients were included in the study; transaminase levels remained unchanged, HCV RNA serum levels decreased significantly and DAS 28 significantly improved after twelve month follow-up. No side effects were registered.
Original language | English |
---|---|
Pages (from-to) | 543-546 |
Number of pages | 4 |
Journal | International Journal of Immunopathology and Pharmacology |
Volume | 22 |
Issue number | 2 |
Publication status | Published - Apr 2009 |
Keywords
- Anti TNF- α
- CsA
- HCV
- Rheumatoid arthritis
ASJC Scopus subject areas
- Immunology
- Immunology and Allergy
- Pharmacology